SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Steve Harmon who wrote (1214)6/24/1998 2:36:00 PM
From: Steve Harmon  Respond to of 2742
 
Bruce Galton,

Do you know what kind of stock support we could have received from many other financial advisors for that kind of deal!!!!!!!

With Bluestone Capital Partners>>>>The market value at CIST has been cut in half!!!



To: Steve Harmon who wrote (1214)6/24/1998 3:29:00 PM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Bruce Galton,

Since the Immunex settlement:

Management at Cistron has made $600,000 in salary and bonuses.
Shareholder value has decreased $7 million.

Cistron needs Welfare Reform!